Telmik-Trio 50 Tablet ER Substitute

Telmik-Trio 50 Tablet ER contains Cilnidipine, Telmisartan, and Metoprolol succinate. Cilnidipine acts on the calcium channels of the blood vessels and suppresses the contraction of blood vessels, thereby helping the blood flow smoothly. Telmisartan works by blocking the angiotensin II receptor, thereby relaxing the blood vessels and lowering the blood pressure. Metoprolol succinate slows down the rate and makes it easier for the heart to pump blood throughout the body. Together, Telmik-Trio 50 Tablet ER helps treat hypertension.

Telmik-Trio 50 Tablet ER may cause a slow heart rate (bradycardia). A minor fluctuation should not be a worry; however, if a slow heart rate continues or you begin to feel unwell, speak with your doctor.

High blood pressure increases the workload on the arteries and heart. If untreated, it could damage the blood vessels of the heart, brain, kidney and might result in stroke, heart failure or kidney failure. Hypertension increases the risk of heart attacks. Therefore, anti-hypertensives such as Telmik-Trio 50 Tablet ER are used to lower the blood pressure to normal; this reduces the risk of developing these disorders.

Please do not stop taking Telmik-Trio 50 Tablet ER without consulting your doctor as it may lead to a rise in blood pressure. To treat your condition effectually, continue taking Telmik-Trio 50 Tablet ER for as long as your doctor has prescribed it to you. Do not be reluctant to speak with your doctor if you experience any difficulty while taking Telmik-Trio 50 Tablet ER.

Orthostatic hypotension could be a side-effect of Telmik-Trio 50 Tablet ER. Orthostatic hypotension is a sudden lowering in blood pressure leading to dizziness on standing. If you experience this, do not try to stand up suddenly or start walking, instead lie down and get up slowly only when you feel better. People taking Telmik-Trio 50 Tablet ER are advised to regularly monitor their blood pressure levels to avoid unpleasant events.